SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-030816
Filing Date
2024-03-13
Accepted
2024-03-13 16:30:39
Documents
13
Period of Report
2024-03-07
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acor-20240307.htm   iXBRL 8-K 40681
2 EX-3.1 acor-ex3_1.htm EX-3.1 123657
  Complete submission text file 0000950170-24-030816.txt   303105

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acor-20240307.xsd EX-101.SCH 25813
14 EXTRACTED XBRL INSTANCE DOCUMENT acor-20240307_htm.xml XML 4892
Mailing Address TWO BLUE HILL PLAZA PEARL RIVER NY 10965
Business Address TWO BLUE HILL PLAZA PEARL RIVER NY 10965 914-347-4300
Acorda Therapeutics, Inc. (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 133831168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31938 | Film No.: 24746373
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)